Glossary

  •  adalimumab: a medicine that is used to relieve symptoms of some autoimmune disorders, such as Crohn’s disease and ulcerative colitis. It works by blocking the action of a substance in the body that causes inflammation (redness and swelling). The brand name of adalimumab is Humira®. Humira is a registered trademark of AbbVie Inc.
  •  allowable (allowed amount): the highest amount that an insurance company will pay for a healthcare service. If your healthcare provider charges more than the allowable, you may have to pay the difference
  •  aminosalicylate: a type of medicine that reduces inflammation in the lining of the gastrointestinal (GI) tract
  •  antibiotic: a type of medicine that is usually used to fight bacteria. Antibiotics are often the first treatment for inflammatory bowel disease (IBD)
  •  antibodies: proteins that the body’s immune system produces when it detects harmful substances, such as bacteria and fungi
  •  autoimmune disorder: a condition that happens when the immune system attacks and destroys healthy tissue in the body. This happens when the immune system can’t tell the difference between healthy tissue and harmful substances, such as bacteria and viruses
  •  coinsurance: the amount you must pay for a covered healthcare service, figured out as a percentage (for example, 20%) of the allowable for the service. You pay coinsurance plus any deductible you owe
  •  colonoscopy: a test that lets your healthcare provider look inside your large intestine. This procedure lets your healthcare provider see things such as swollen tissue, abnormal growths, and sores
  •  co-payment: a fixed amount that you pay for a covered healthcare service. The amount can vary by the type of covered healthcare service
  •  corticosteroid: a type of medicine that affects the body’s ability to start and maintain inflammation. Corticosteroids are helpful for short-term control of flare-ups. They are not used for long periods at a time, because they have side effects
  •  Crohn’s disease: one of the 2 most common types of inflammatory bowel disease. Crohn’s disease causes inflammation in any part of the digestive system, from the mouth to the anus
  •  deductible: the amount you must pay before your health insurance begins to pay. The deductible may not apply to some services. Out-of-network deductibles may be different from in-network deductibles
  •  flare-up: a sudden worsening of a disease
  •  gastrointestinal (GI) tract: the long series of body parts that break down and absorb the food a person eats. The GI tract extends from the mouth to the anus
  •  IBD: see inflammatory bowel disease (IBD)
  •  immunomodulator: a type of medicine that helps stop the body’s immune system from causing ongoing inflammation. Immunomodulators are often used when corticosteroids and aminosalicylates are not effective enough
  •  inflammation: redness and swelling in body tissue. Inflammation occurs when the body responds to an injury or damage of the tissue
  •  inflammatory bowel disease (IBD): a group of disorders in which the bowels (the small intestine and the large intestine) become red and swollen. The most common forms of IBD are Crohn’s disease and ulcerative colitis
  •  infliximab: a medicine that is used to relieve symptoms of some autoimmune disorders, such as Crohn’s disease, ulcerative colitis, and rheumatoid arthritis. It works by blocking the action of a substance in the body that causes inflammation (redness and swelling). The brand name of infliximab is Remicade®. Remicade is a registered trademark of Janssen Biotech, Inc.
  •  marker: something that identifies, predicts, or characterizes. A biomarker may mark a process (such as aging) or a condition (such as a disease). A genetic marker may mark a trait or part of a gene
  •  PROMETHEUS® Anser™ ADA: a blood test that your healthcare provider may order if your symptoms of inflammatory bowel disease (IBD) return. The test tells how much adalimumab is in your body. This may help your healthcare provider figure out how well your treatment may be working
  •  PROMETHEUS® Anser™ IFX: a blood test that your healthcare provider may order if symptoms of inflammatory bowel disease (IBD) return. The test tells how much infliximab is in your body. This may help your healthcare provider figure out how well your treatment may be working
  •  PROMETHEUS® IBD sgi Diagnostic™: a blood test that your healthcare provider may order if you have symptoms of inflammatory bowel disease (IBD). The test may help your healthcare provider see whether you have IBD and, if so, what type of IBD you have: Crohn’s disease or ulcerative colitis
  •  remission: when symptoms of a disease go away
  •  ulcerative colitis: one of the 2 most common types of inflammatory bowel disease (IBD). Ulcerative colitis causes swelling and sores in the large intestine (colon)